Irmantas Rokaitis

Chief Technology Officer at Biomatter Designs

Irmantas Rokaitis has worked in the field of biochemistry since 2016. Irmantas began their career as a Research and Development Scientist for iGEM "Vilnius-Lithuania" where they developed an innovative method for high-throughput biomolecule characterization called Catalytic Activity Sequencing (CAT-Seq). Irmantas also modified the ColE1 replicon to create a synthetic origin of replication called SynORI. In 2018, they began working at Vilnius University, Institute of Biochemistry as a Researcher. Irmantas also took on the role of Head of Production at Biomatter Designs.

Irmantas Rokaitis obtained a Master's degree in Biochemistry from Vilnius University in addition to a Bachelor's degree in Biochemistry from the same institution.

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Biomatter Designs

Pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.


Industries

Headquarters

Vilnius, Lithuania

Employees

11-50

Links